LabCritics

Follow us to know about new Lab Tech, Software and Services, even consumables... Reach out if you are building for researchers

[LabCritics @LabCritics]

- Vitrify: molecular simulations beyond DFT accuracy
- Biomni + Bayer: AI agent deployment for drug discovery
- Atomwell: Release of Bindwell's binding affinity model

[LabCritics @LabCritics]

The last 48 hours in #AIxBio
- Boltz + Bristol Myers Squibb: deploy biomolecular AI models
- Warp Sciences: AI x robotic CRO labs for drug discovery
- Carbon-X: Enables conversations with DNA, open model for DNA interpretation by hugging face

[LabCritics @LabCritics]

- Nanograb: AI for in vivo targeted drug delivery with lipid nanoparticles
- Holon-S1: Sophont and MedARC announce model for identifying cancer biomarkers from pathology slides
- Pinal: Model for protein design using plain language

[LabCritics @LabCritics]

- OpenAI acquires Orchestra Bio
- Artios: Open source enzyme design model
- OpenAI + PerturbAI: agents find brain disease clues
- Xaira Announces X-Scientist: A Self Improving AI drug Discover platform

[LabCritics @LabCritics]

This week in AIxBio

- Omnii-1 by Radical Numerics: AI-designed phage reaches human patient
- Claude designs scorpion toxin binders, yet to test in humans
- Baker Lab: RFD4-Proteina
- Chaperone: agent framework for protein design
- BioEmu2: protein simulations

[LabCritics @LabCritics]

How soon before we see the first cases of Drug Squatting?

Drug discovery is getting cheaper, its only a matter of time before random people start patenting drug designs instead of pursuing them..

Like Domain Squatting, drug squatting will soon become a pain for pharma..

[LabCritics @LabCritics]

@minchoi Very soon humans won't be able to distinguish between busllshit "discoveries" and real discovery, because there won't be anyone with enough knowlege to tell them apart..

[LabCritics @LabCritics]

@AnthropicAI Hey Anthropic, what category do research focused websites such as https://t.co/b67LhMSNT2 fall into? We use Claude for research on a regular basis?

[LabCritics @LabCritics]

@genselectai We love this.. would you be interested in a integrating a panel on our website.. Helping you increase discovery?

[LabCritics @LabCritics]

@StanfordMed How is this different from uploading a paper on Claude and asking it questions related to the same?? Collaboration between two papers is not of any significance without the larger context..

[Eric Topol @EricTopol]

AlphaFold: predicting the protein structure from amino acid sequence for >200 million proteins (awarded @NobelPrize)

Today
Alpha Genome Atlas: predicting the molecular impact of all 9 billion variants of the human genome

https://t.co/DkEtZofJ8s

[LabCritics @LabCritics]

AI Biodesign Accelerator: Moving From Blind Prediction to Guided Experimentation @AllenInstitute https://t.co/vDYOu48pVZ #AIxBio

[LabCritics @LabCritics]

The next generation of #LIMS and #ELN need deep AI integration.. @openAI and @AnthropicAI need to move into #LIMS at the earliest..

[LabCritics @LabCritics]

@rickwierenga @genentech @pylabrobot @Anthropic We have a few questions..? Why can't MHS connect with API's, is it a hardware issue or translation issue?

[LabCritics @LabCritics]

Check out our Full piece + the 10-question buyer checklist: https://t.co/t7fsBCxPgB

[LabCritics @LabCritics]

Why Lab Automation is a nightmare?

Your $30 smart bulb speaks an open standard.

Your $300,000 liquid handler doesn't.

A thread on lab automation's most embarrassing failure

[LabCritics @LabCritics]

The vendors that treat openness as architecture — open control, open state, open data, no API toll booth — will own the AI-lab decade. The rest get designed out.

If your instrument needs its maker's permission to be useful, it's not an instrument. It's a subscription with a deck